Related Articles
DOUBLE-MODULATION OF 5-FLUOROURACIL BY METHOTREXATE AND LEUCOVORIN IN ADVANCED COLORECTAL-CARCINOMA
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors
Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer
Multicenter phase II study of infusional 5‑fluorouracil (5‑FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first‑line treatment in patients with metastatic colorectal cancer (CELINE trial)
Phase I study of 5‑fluorouracil, leucovorin and bevacizumab in combination with radiation therapy in patients with locally advanced rectal cancer